Adverum Biotechnologies
ADVM
$7.33
Share price
-7.06%
Change (1 day)
-66.22%
Change (1 year)
Operating Margin for Adverum Biotechnologies (ADVM)
Operating Margin as of March 2025 (TTM): -815.60%
According to Adverum Biotechnologies 's latest financial reports and stock price the company's current Operating Margin is -815.60%. At the end of 2023 the company had an Operating Margin of -3,284.53%.
Operating Margin history for Adverum Biotechnologies from 2014 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -3,284.53% | |
| 2021 | -1,940.53% | |
| 2019 | -25,794.40% | 462.84% |
| 2018 | -4,582.94% | 50.92% |
| 2017 | -3,036.61% | -61.42% |
| 2016 | -7,870.93% | 284.65% |
| 2015 | -2,046.27% | -53.93% |
| 2014 | -4,441.26% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.